Next Article in Journal
Coumarin– and Dipicolylamine–Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer Potential
Previous Article in Journal
ComTarget: Small-Molecule Target Prediction with Combinatorial Modeling
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Copper (Cu2+) Inhibits Voltage-Dependent Ionic Currents While Enhancing Neurotransmitter Release in Bovine Chromaffin Cells

by
Víctor Varea-Tierno
1,†,
Victoria Jiménez Carretero
1,†,
Minerva Reyes Almodóvar
1,
Javier Hernández Campano
1,
María Arribas Tejedor
1,
Ricardo de Pascual
1 and
Jesús M. Hernández-Guijo
1,2,*
1
Department of Pharmacology and Therapeutics, Facultad de Medicina, Universidad Autónoma de Madrid, Av. Arzobispo Morcillo 4, 28029 Madrid, Spain
2
Ramón y Cajal Institute for Health Research, IRYCIS, Hospital Ramón y Cajal, Ctra. de Colmenar Viejo, 28034 Madrid, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceuticals 2026, 19(5), 716; https://doi.org/10.3390/ph19050716
Submission received: 11 March 2026 / Revised: 23 April 2026 / Accepted: 27 April 2026 / Published: 30 April 2026
(This article belongs to the Section Medicinal Chemistry)

Abstract

Background/Objectives: Copper (Cu2+) is an essential trace element that participates as a cofactor in key metabolic enzymes such as cytochrome c oxidase and superoxide dismutase. However, excessive copper exposure can be toxic and disturbances in copper homeostasis have been associated with neurodegenerative diseases including Alzheimer’s and Parkinson’s disease. Despite growing evidence linking copper to neuronal dysfunction, the cellular mechanisms by which Cu2+ affects neuronal excitability and neurotransmission remain poorly understood. The aim of this study was to investigate the effects of acute Cu2+ exposure on ionic currents involved in cellular excitability and neurotransmitter release in bovine chromaffin cells. Methods: Primary cultures of bovine chromaffin cells were used as a neuroendocrine model to study cellular excitability. Voltage-dependent ionic currents were recorded using the whole-cell patch-clamp technique in voltage-clamp configuration. Catecholamine secretion was monitored by amperometry, and cytosolic Ca2+ dynamics were measured in fluo-4-loaded cells during depolarization induced by high K+ stimulation. Results: Acute Cu2+ exposure produced a concentration-dependent enhancement of depolarization-evoked catecholamine release. In parallel, Cu2+ inhibited voltage-dependent calcium (ICa), sodium (INa), potassium (IKv), and calcium/voltage-dependent potassium (IKCa-v) currents in a concentration-dependent and partially reversible manner. In addition, Cu2+ increased basal cytosolic Ca2+ levels while reducing the amplitude of depolarization-evoked Ca2+ transients. Conclusions: Acute Cu2+ exposure exerts a dual effect in bovine chromaffin cells, inhibiting the ionic currents that support cellular excitability while potentiating catecholamine secretion. This apparent paradox is consistent with a disruption of intracellular Ca2+ homeostasis, in which elevated basal cytosolic Ca2+ may facilitate exocytosis despite reduced depolarization-evoked Ca2+ entry. These findings provide new insight into the mechanisms by which copper may alter neuronal signaling and contribute to neurotoxicity.

Graphical Abstract

1. Introduction

Copper (Cu2+) is an essential trace element required for multiple biological processes. As a redox-active metal, copper acts as a cofactor for key enzymes involved in oxidative metabolism, antioxidant defense, iron homeostasis, and neurotransmitter synthesis, including cytochrome c oxidase, superoxide dismutase, ceruloplasmin, and dopamine-β-monooxygenase [1,2,3,4,5,6]. In the nervous system, copper also contributes to brain development, neuromodulation, and myelination [1,7,8,9,10]. However, because of its high redox reactivity, dysregulated copper can also promote oxidative stress and cellular damage [11].
In the brain, copper is tightly regulated and unevenly distributed among regions and subcellular compartments [10,12,13,14,15,16,17,18]. Although cerebrospinal fluid copper concentrations are relatively low, extracellular copper levels in neural tissue may rise substantially under physiological conditions, particularly after neuronal depolarization [19,20]. In addition, most brain copper is protein-bound and localized in cytosolic, mitochondrial, synaptic vesicle, synaptosomal, and endosomal compartments, supporting the idea that copper participates in neuronal signaling as well as in general cellular metabolism [10,15,18].
Increasing evidence indicates that copper modulates synaptic function. Copper has been reported to affect neurotransmission through actions on GABA and NMDA receptors and on voltage-gated ion channels, including Ca2+ and K+ channels [21,22,23,24,25,26,27]. These observations suggest that copper may influence neuronal excitability and stimulus–secretion coupling. At the same time, disruption of copper homeostasis has been linked to several neurological disorders, including Menkes disease, Wilson disease, Alzheimer’s disease, and Parkinson’s disease [1,15,28,29,30,31]. In these conditions, abnormal copper handling may contribute to neuronal dysfunction through oxidative stress, altered protein aggregation, and defective synaptic signaling.
Despite this growing evidence, the acute cellular mechanisms by which Cu2+ modifies excitability and neurotransmitter release are still not fully understood. In particular, it remains unclear how copper simultaneously affects the voltage-dependent ionic currents that support action potential generation and the calcium-dependent processes that govern exocytosis. A better definition of these mechanisms is important for understanding how copper excess may alter neuronal communication and contribute to neurotoxicity.
To address this issue, we used primary cultures of bovine chromaffin cells, a well-established neuroendocrine model for the study of cellular excitability and regulated catecholamine secretion [32,33,34]. Chromaffin cells share key functional properties with sympathetic neurons, including the expression of voltage-dependent Na+, Ca2+, and K+ channels and the capacity to synthesize, store, and release catecholamines [32,33,34]. Using this model, we investigated the acute effects of Cu2+ on catecholamine release, voltage-dependent Ca2+, Na+, K+, and Ca2+/voltage-dependent K+ currents, as well as on cytosolic Ca2+ dynamics. Our aim was to determine how copper alters the ionic and calcium-dependent mechanisms that control neurotransmitter release.

2. Results

2.1. Cu2+ Increases Neurotransmitter Release

Chromaffin cells constitute a well-established experimental model for the study of the molecular mechanisms underlying cellular excitability and regulated neurotransmitter secretion [35,36,37]. These cells express voltage-gated Na+, K+, and Ca2+ channels, which are essential for the maintenance of the resting membrane potential, the generation of action potentials, and the control of stimulus–secretion coupling [38].
In the experiment shown in Figure 1, chromaffin cells superfused with Krebs–HEPES solution exhibited a stable basal spontaneous catecholamine release of approximately 2 nA. Depolarizing stimuli were applied using 10 s pulses of a solution containing 35 mM K+ (35K), which evoked catecholamine secretion peaks of approximately 197 nA. When K+ pulses were applied repeatedly at 1 min intervals, a gradual decline in secretion amplitude was observed, as shown in the control condition (Figure 1A).
To evaluate the effect of copper, cells were superfused with a single concentration of Cu2+ (0.1, 0.3, 1, 3, or 10 μM) from pulses P7 to P16. The presence of Cu2+ produced a marked increase in the amplitude of K+-evoked secretory responses. Figure 1A illustrates the normalized time course of catecholamine release in the presence of the different Cu2+ concentrations. Catecholamine secretion increased to 236%, 246%, 294%, 359%, and 559% for 0.1, 0.3, 1, 3, and 10 μM Cu2+, respectively, relative to pulse P6 (immediately before Cu2+ application), after correction for the spontaneous signal decay observed in control experiments. Following Cu2+ washout (pulse P17), secretion decreased markedly and returned to control levels.
Figure 1C shows the concentration–response relationship for Cu2+-induced potentiation of catecholamine release. At the end of Cu2+ application, catecholamine release potentiation reached 136.18 ± 13.10%, 146.04 ± 14.24%, 194.46 ± 22.29%, 259.26 ± 17.85%, and 458.54 ± 41.66% for 0.1, 0.3, 1, 3, and 10 μM Cu2+, respectively, relative to pulse P6, taking into account the 31.12% spontaneous signal reduction observed in control experiments at pulse P16.

2.2. Time- and Concentration-Dependent Blockade of ICa by Copper

In a second series of experiments, we investigated whether the modulation of calcium conductance involved in neurotransmitter secretion could account for the Cu2+-induced increase in catecholamine release. In the experiments shown in Figure 2, individual voltage-clamped chromaffin cells were stimulated with 50 ms depolarizing pulses to 0 mV, applied at 10 s intervals from a holding potential of −80 mV. Inward calcium currents (ICa) were recorded using 10 mM extracellular Ca2+ as the charge carrier. In 67 cells tested, the mean peak current amplitude was 685 ± 50 pA. This current remained stable during the approximately 5 min recording period; cells showing noticeable current rundown were excluded from the analysis.
Once the current reached a stable baseline, each cell was superfused with a single concentration of Cu2+ until the effect stabilized for at least 2 min. Partial washout of Cu2+ prevented the construction of cumulative concentration–response curves in the same cell. To minimize variability between recordings, currents were normalized to the maximal current obtained at the beginning of each experiment (ICa/ICa max).
Figure 2A shows the averaged time course of ICa inhibition produced by five Cu2+ concentrations (3, 10, 30, 100, and 300 µM), demonstrating a clear concentration-dependent blocking effect. Figure 2B shows representative current traces under control conditions and after 2 min superfusion with Cu2+ (30 μM). Figure 2C illustrates the concentration–response curve for Cu2+-induced inhibition of peak ICa. The degree of inhibition measured at the end of the superfusion period was 14 ± 4%, 37 ± 5%, 47 ± 4%, 65 ± 6%, and 85 ± 3% for 3, 10, 30, 100, and 300 μM Cu2+, respectively (n = 7). The IC50 value was 45.7 μM. After washout, partial recovery of the current was observed, reaching 76 ± 8%, 69 ± 6%, 64 ± 8%, 62 ± 4%, and 61 ± 9% of the control current for 3, 10, 30, 100, and 300 μM Cu2+, respectively.
In an additional set of experiments, voltage-clamped chromaffin cells were stimulated with depolarizing pulses (50 ms) of increasing amplitude applied at 10 s intervals from a holding potential of −80 mV, before and after 2 min superfusion with Cu2+, using 10 mM Ca2+ as the charge carrier. The current–voltage (I–V) relationship under control conditions showed that peak ICa activation began at approximately −20 mV, reached a maximum at +10 mV, and reversed near +60 mV (Figure 3). After 2 min exposure to Cu2+ (30 μM), the I–V relationship showed a slight shift toward more negative potentials, with activation beginning around −30 mV and the peak current occurring at 0 mV. Additionally, a statistically significant reduction in ICa amplitude was observed at 10 and 20 mV (see original traces in Figure 3).

2.3. Time- and Concentration-Dependent Blockade of INa by Copper

In a subsequent series of experiments, we evaluated the effect of Cu2+ on voltage-gated sodium channels, which are responsible for the initiation and propagation of action potentials. In the experiments shown in Figure 4, individual voltage-clamped chromaffin cells were stimulated with 10 ms depolarizing pulses to −10 mV, applied at 10 s intervals from a holding potential of −80 mV. The mean initial sodium current (INa) amplitude was 406 ± 45 pA (n = 27). The current remained stable during the approximately 5 min recording period; cells showing signs of current rundown were excluded from analysis.
After stabilization of the initial current, each cell was superfused with a single concentration of Cu2+ until the effect reached a steady state for at least 2 min. To reduce variability between recordings, currents were normalized to the maximal current measured at the beginning of each experiment (INa/INa max).
Figure 4A shows the averaged time course of INa inhibition produced by four concentrations of Cu2+ (1, 3, 10, and 30 μM), demonstrating a clear concentration-dependent blocking effect. Figure 4B presents representative current traces under control conditions and after 2 min superfusion with Cu2+ (10 μM). Figure 4C shows the concentration–response relationship for Cu2+-induced inhibition of peak INa. The inhibition measured at the end of the 2 min superfusion period was 13 ± 4%, 18 ± 3%, 41 ± 6%, and 99 ± 0.7% for 1, 3, 10, and 30 μM Cu2+, respectively (n = 5–6). The calculated IC50 value for Cu2+ inhibition of INa was 17.00 μM.
The calculated IC50 value was 17.00 µM. Data were normalized to the mean control value and are expressed as mean ± SEM (n = 5–10 experiments; Wilcoxon matched-pairs signed-rank test).
A separate set of voltage-clamped chromaffin cells was stimulated with 10 ms depolarizing pulses of increasing amplitude applied at 10 s intervals from a holding potential of −80 mV, both before and 2 min after superfusion with Cu2+. The current–voltage (I–V) relationship under control conditions showed that peak I_Na activation began at approximately −30 mV, reached a maximum at −10 mV, and reversed near +20 mV (Figure 5). After 2 min exposure to Cu2+ (10 μM), no significant shift in the I–V relationship was observed. However, Cu2+ produced a stronger inhibition of I_Na at more negative potentials than at positive potentials, as illustrated in the original current traces (Figure 5).

2.4. Time- and Concentration-Dependent Blockade of IKv by Copper

In chromaffin cells, as in most excitable cell types, K+ currents are primarily responsible for membrane repolarization. In these cells, potassium currents are mediated by both voltage-dependent K+ channels and Ca2+-activated voltage-dependent K+ channels [39]. In the experiments shown in Figure 6, the effects of Cu2+ on the voltage-dependent potassium current (IKv) were investigated.
Individual voltage-clamped cells were stimulated with 45 ms depolarizing pulses to +120 mV, applied at 10 s intervals from a holding potential of −80 mV. In 48 cells tested, the mean current amplitude was 1637 ± 134 pA. The current remained stable during the approximately 5 min recording period, and cells showing signs of current rundown were excluded from the analysis.
Once the initial current stabilized, each cell was superfused with a single concentration of Cu2+ until the effect reached a steady state after approximately 2 min. Partial washout of Cu2+ prevented the construction of cumulative concentration–response curves in the same cell. To minimize variability between recordings, currents were normalized to the maximal current recorded at the beginning of each experiment (IKv/IKv max).
Figure 6A shows the averaged time course of I_Kv inhibition produced by six concentrations of Cu2+ (1, 3, 10, 30, 100, and 300 μM), demonstrating a concentration-dependent inhibitory effect. Figure 6B shows representative current traces under control conditions and after 2 min superfusion with Cu2+ (10 μM). Figure 6C shows the concentration–response relationship for Cu2+-induced inhibition of peak IKv. The inhibition measured at the end of the 2 min superfusion period was 21 ± 2%, 30 ± 6%, 37 ± 2%, 62 ± 4%, 70 ± 5%, and 70 ± 1% for 1, 3, 10, 30, 100, and 300 μM Cu2+, respectively (n = 5–7). The calculated IC50 value for Cu2+ inhibition of I_Kv was 11.25 μM.
A separate set of voltage-clamped chromaffin cells was stimulated with 45 ms depolarizing pulses of increasing amplitude applied at 10 s intervals from a holding potential of −80 mV, both before and after 2 min superfusion with Cu2+. The current–voltage (I–V) relationship under control conditions showed that I_Kv activation began at approximately −25 mV (Figure 7). After 2 min exposure to Cu2+ (10 μM), the I–V relationship did not show significant changes in its kinetic parameters. However, Cu2+ reduced the current amplitude at potentials of +20 mV and above, indicating a decrease in current magnitude without significant alterations in activation properties.

2.5. Copper Induced a Blockade of the Calcium Modulated Voltage-Dependent Potassium Channels

Activation of outward K+ currents is essential for the rapid repolarization and termination of action potentials in chromaffin cells. Although the precise spatial distribution of Ca2+ channels in chromaffin cells remains unclear, it has been suggested that voltage-dependent Ca2+ channels are located in close proximity to BK channels [40,41].
In the experiments shown in Figure 8, cells were first depolarized to +20 mV for 30 ms to induce Ca2+ influx through voltage-dependent Ca2+ channels. This pre-pulse was followed by a depolarizing step to +120 mV for 400 ms from a holding potential of −80 mV. At +120 mV, Ca2+ influx ceases, and the Ca2+-activated voltage-dependent potassium current (IKCa-v) is activated. In the absence of the 30 ms pre-pulse, no Ca2+-dependent current was activated, and the outward current recorded corresponded exclusively to Ca2+-independent voltage-activated K+ channels. Following the Ca2+ influx induced by the pre-pulse, more than 90% of the total K+ current became available for activation. The IKCa-v current decayed rapidly and completely after closure of Ca2+ channels. The decay of intracellular Ca2+ concentration after termination of Ca2+ influx is determined by intracellular Ca2+ buffering properties and Ca2+ extrusion mechanisms.
Using this pre-pulse protocol (see Figure 8B), the effects of Cu2+-induced blockade of Ca2+ influx on IKCa-v activation were evaluated. Figure 8A shows the time course of current inhibition produced by Cu2+ at concentrations of 0.3, 1, 3, and 10 µM. Cu2+ reduced IKCa-v by 18 ± 3% at 0.3 µM (n = 5), 33 ± 3% at 1 µM (n = 5), 55 ± 2% at 3 µM (n = 6), and 70 ± 2% at 10 µM (n = 5), from an initial IKCa-v amplitude of 1169 ± 74 nA. Figure 8B shows representative IKCa-v current traces under control conditions (a) and after 2 min superfusion with Cu2+ (10 μM) (b). Inhibition of IKCa-v was measured in each individual cell at the end of the 2 min superfusion period for each Cu2+ concentration, and the calculated IC50 value was 1.39 μM (Figure 8C).
Depolarizing steps that induce Ca2+ influx through voltage-dependent Ca2+ channels also activate Ca2+/voltage-dependent K+ channels, which can be identified by a characteristic hump in the current–voltage (I–V) relationship (Figure 9A). In this set of experiments, the effects of Cu2+ on the Ca2+-activated voltage-dependent potassium current (IKCa-v) were further examined.
Outward K+ currents were activated by 400 ms depolarizing pulses applied every 10 s from a holding potential of −80 mV in +10 mV increments, using 2.5 mM external Ca2+ as a function of membrane potential. Under control conditions, IKCa-v showed a threshold of activation at approximately −20 mV, and the I–V relationship displayed a pronounced hump. This hump closely resembled the current–voltage relationship of the Ca2+ current in these cells, consistent with the Ca2+ dependence of this potassium current.
After 2 min application of Cu2+ (1 μM), a substantial reduction in peak IKCa-v was observed. Following Cu2+ treatment, the residual current–voltage relationship exhibited a more linear profile, indicating a reduced contribution of Ca2+-activated K+ channels to the total outward current.
Figure 9B shows representative current traces recorded at +10 mV, +50 mV, and +90 mV under control conditions and after application of Cu2+ (1 μM). A marked reduction in IKCa-v amplitude was observed after Cu2+ exposure, particularly between +10 mV and +90 mV, where the contribution of Ca2+/voltage-dependent K+ channels to the total outward K+ current is greater than at more depolarized potentials.

2.6. Effects of Cu2+ on the Cytosolic Calcium Transients

After observing that Cu2+ enhanced neurotransmitter release evoked by depolarizing stimuli with high extracellular K+ concentrations, while simultaneously inhibiting Ca2+ entry currents as well as INa, IK, and IKCa-v, this apparent paradox led us to investigate whether Cu2+ could affect cytosolic calcium levels, which may modulate both neurotransmitter release and voltage-dependent calcium channels. Such an effect could help explain the increase in neurotransmission despite the inhibition of ICa.
To address this question, cytosolic Ca2+ mobilization was measured in populations of chromaffin cells stimulated with high K+ concentrations (35 mM). Cells were loaded with Fluo-4 AM and fluorescence signals were recorded (see Section 4). As shown in Figure 10, Cu2+ reduced the increase in cytosolic calcium concentration ([Ca2+]c) elicited by depolarizing pulses of 35 mM K+. However, Cu2+ markedly increased basal cytosolic calcium levels prior to stimulation.
Figure 10A shows a family of [Ca2+]c traces normalized to the initial baseline under control conditions and in the presence of the indicated Cu2+ concentrations. Calibration bars represent changes in arbitrary fluorescence units (AFU) over time (s). Figure 10B shows representative [Ca2+]c signals expressed in absolute AFU values as a function of time. These traces illustrate the increase in basal [Ca2+]c induced by exposure to increasing Cu2+ concentrations before stimulation with 35 mM K+ pulses, as well as the subsequent Ca2+ elevations elicited by depolarization. Notably, the basal [Ca2+]c level progressively increased with Cu2+ concentration in each trace. Curves represent averages from six experiments performed in two different cell cultures.
Quantitative averaged data for the net [Ca2+]c increase elicited by 35 mM K+ are summarized in Figure 10C. Cu2+ produced a concentration-dependent inhibition of the K+-evoked calcium signal, ranging from 25.7 ± 6.3% inhibition at 1 μM to 45.9 ± 7.7% inhibition at 10–30 μM Cu2+. Finally, Figure 10D shows the net increases in basal fluorescence (after subtracting the control baseline) induced by increasing Cu2+ concentrations before the 35 mM K+ stimulus. Cu2+ significantly elevated basal [Ca2+]c starting at 0.1 μM in a concentration-dependent manner, reaching values above 4000 AFU at higher Cu2+ concentrations.
Finally, Figure 11 summarizes the main findings of the present study and illustrates the mechanism proposed to explain the paradoxical effect of Cu2+ in bovine chromaffin cells. Acute exposure to Cu2+ inhibits the major voltage-dependent ionic currents involved in cellular excitability, including Ca2+ currents (ICa), Na+ currents (INa), voltage-dependent K+ currents (IKv), and Ca2+/voltage-dependent K+ currents (IKCa-v, BK). In parallel, Cu2+ reduces the cytosolic Ca2+ transients evoked by depolarization with high extracellular K+, consistent with the inhibition of Ca2+ entry through voltage-dependent Ca2+ channels. However, Cu2+ also increases basal cytosolic Ca2+ levels. Taken together, these findings suggest that the enhancement of catecholamine release observed in the presence of Cu2+ is not due to an increase in depolarization-evoked Ca2+ influx, but rather to an alteration of intracellular Ca2+ homeostasis, whereby the elevation of basal cytosolic Ca2+ facilitates exocytosis despite the inhibition of inward ionic currents.

3. Discussion

In the present study, we analyzed the effects of acute copper (Cu2+) exposure on the excitability of bovine chromaffin cells by examining its effects on voltage-dependent calcium, sodium, and potassium currents, Ca2+-activated potassium currents, intracellular calcium dynamics, and neurotransmitter release. Our results show that Cu2+ produces multiple effects on chromaffin cells: (1) an increase in catecholamine release, (2) a gradual and partially reversible blockade of voltage-dependent Ca2+ currents, (3) a pronounced inhibition of voltage-dependent Na+ currents, (4) inhibition of voltage-dependent K+ conductance, (5) inhibition of Ca2+/voltage-dependent K+ currents, and (6) an increase in intracellular calcium levels.
Copper is an essential trace element that plays important roles in numerous biological and metabolic processes [12]. However, excessive or uncontrolled exposure to copper can have detrimental effects on human health [15]. Environmental copper levels have increased due to anthropogenic activities such as mining, industrial processes, and fossil fuel combustion, leading to increased human exposure [42]. Copper can enter the body through ingestion of contaminated water or inhalation of airborne particles [1], and copper compounds are widely used in agriculture and industry, further contributing to exposure [43]. Once in the body, copper can accumulate and has been associated with neurological disorders and neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis [1]. One of the primary mechanisms proposed for copper neurotoxicity involves the generation of reactive oxygen species (ROS), leading to oxidative stress and neuronal damage [11].
In this study, we focused on the acute effects of Cu2+ on ionic currents responsible for cellular excitability and neurotransmitter release. We found that acute Cu2+ exposure stimulates evoked catecholamine release in a concentration-dependent manner. Calcium ions play a fundamental role in neurotransmitter release due to their influx through voltage-dependent calcium channels, mainly N- and P-type channels in neurons and L-type channels in neuroendocrine cells [44,45,46]. Our results show that ICa is blocked by Cu2+ in a time- and dose-dependent manner, with a reversible blockade and an IC50 of 45.7 µM. At the highest concentrations tested (300 µM), calcium influx was reduced by approximately 90%, indicating that multiple Ca2+ channel subtypes present in chromaffin cells are affected. The inhibition of ICa was more pronounced at negative potentials, and Cu2+ produced a slight shift in the I–V relationship toward more negative voltages.
Voltage-dependent Na+ channels are responsible for the depolarizing current that initiates action potentials in most excitable cells [47]. Our results show that Cu2+ blocks sodium currents in a time- and dose-dependent and reversible manner, with an IC50 of 17.00 µM. The highest concentration tested (30 µM) completely suppressed INa, indicating a strong effect of Cu2+ on Na+ channel activity. However, Cu2+ did not significantly shift the I–V relationship or alter the kinetic parameters of sodium currents.
Potassium channels play a crucial role in repolarization of the action potential, regulation of resting membrane potential, and modulation of cellular excitability and firing patterns [48]. In chromaffin cells, potassium currents are mediated by both voltage-dependent K+ channels and Ca2+-activated K+ channels (BK channels) [49,50]. Our results show that Cu2+ inhibits voltage-dependent K+ currents with an IC50 of 11.25 µM without significant changes in the I–V relationship. Additionally, Cu2+ inhibited BK currents in a reversible and concentration-dependent manner, with an IC50 of 1.39 µM, indicating that Ca2+-activated K+ channels are particularly sensitive to Cu2+.
The mechanisms responsible for cytosolic calcium extrusion are essential for maintaining calcium homeostasis and include the Na+/Ca2+ exchanger [51], plasma membrane Ca2+-ATPase [52], sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) [53], and mitochondrial calcium transport systems [54,55]. These mechanisms work together to maintain cytosolic calcium within a physiological range. The blockade of these mechanisms by Cu2+ could lead to accumulation of calcium in the cytosol, which in turn could result in excessive neurotransmitter release and disruption of synaptic signaling. Elevated cytosolic calcium may also induce mitochondrial production of reactive oxygen species, contributing to oxidative stress and neuronal dysfunction.
One of the most important findings of this study is the apparent paradox that Cu2+ enhances neurotransmitter release while simultaneously inhibiting voltage-dependent Ca2+ currents. Measurements of cytosolic Ca2+ provide a possible explanation for this observation. Cu2+ significantly increased basal cytosolic Ca2+ levels while reducing the Ca2+ transients evoked by depolarization with high K+. This suggests that Cu2+ disrupts intracellular calcium homeostasis, possibly by inhibiting calcium extrusion mechanisms or by mobilizing calcium from intracellular stores such as the endoplasmic reticulum or mitochondria. The increase in basal cytosolic Ca2+ could facilitate vesicle priming and fusion, thereby enhancing neurotransmitter release despite reduced Ca2+ influx through voltage-dependent calcium channels.
Additionally, Cu2+ has been reported to inhibit Na+/K+-ATPase activity, which could increase intracellular Na+ concentration and reverse the operation of the Na+/Ca2+ exchanger, leading to increased intracellular Ca2+ levels [56]. Heavy metals, including Cu2+, also inhibit plasma membrane Ca2+-ATPase activity at micromolar concentrations [57,58]. Since calcium transport ATPases and copper transport ATPases belong to the P-type ATPase family and share similar catalytic mechanisms, Cu2+ may interfere with Ca2+ transport processes when present in the cytosol [59,60]. Furthermore, Cu2+ may affect mitochondrial function and the mitochondrial calcium uniporter, further contributing to alterations in intracellular calcium regulation [61].
An additional point that deserves consideration is the coordinated role of inward and outward ionic currents in shaping catecholamine secretion. Recent reviews emphasize that stimulus–secretion coupling in chromaffin cells is not determined exclusively by the magnitude of Ca2+ entry, but by the dynamic interaction between depolarizing and repolarizing conductances that define action potential waveform, firing frequency, and intracellular Ca2+ handling [38,62]. At the onset of stimulation, inward cationic currents through nicotinic receptors, together with voltage-dependent Na+ currents, provide the depolarizing drive required to recruit high-voltage-activated Ca2+ channels [63]. Ca2+ influx through these channels is the immediate trigger for vesicle fusion and catecholamine release. However, recent evidence indicates that the final secretory response also depends on the contribution of intracellular Ca2+ stores and mitochondrial Ca2+ buffering, indicating that exocytosis reflects integrated Ca2+ homeostasis rather than Ca2+ influx alone. In parallel, outward K+ currents, including voltage-dependent K+ currents and Ca2+-activated K+ currents, are critical for action potential repolarization, spike duration, and interspike interval, and therefore strongly influence both the amount and temporal profile of Ca2+ entry [38]. From this perspective, inhibition of outward K+ conductances may prolong depolarization and transiently favor exocytosis, whereas inhibition of inward Na+ and Ca2+ currents would be expected to reduce cellular excitability and secretory capacity. Thus, the final effect of Cu2+ on catecholamine release is likely to result from the balance between these opposing actions on membrane excitability and from its additional ability to alter basal cytosolic Ca2+ levels.
Overall, our findings indicate that Cu2+ exerts a dual effect on neuronal function by inhibiting ionic currents required for action potential generation and propagation while simultaneously enhancing neurotransmitter release through disruption of intracellular calcium homeostasis. The paradoxical increase in exocytosis despite inhibition of Ca2+ entry currents can be explained by an elevation of basal cytosolic Ca2+ levels and altered calcium handling mechanisms.
Another mechanism that may contribute to the effects of Cu2+ is its behavior as a labile extracellular cation capable of modifying the ionic microenvironment at the outer membrane surface. Current reviews indicate that weakly bound copper pools can be released during neuronal activity and transiently accumulate in restricted extracellular compartments, where they modulate neuronal excitability and Ca2+ homeostasis [64,65,66]. In this context, extracellular Cu2+ may alter the local electrostatic environment near the membrane by screening negatively charged surface groups and by competing with other cations for external binding sites, thereby modifying channel gating and voltage dependence [65].
In addition to these surface charge effects, Cu2+ can also act through direct coordination to membrane proteins, frequently involving extracellular amino acid residues able to bind transition metals. In agreement with this idea, direct extracellular Cu2+-binding sites have been identified in BK and Shaker K+ channels, where Cu2+ produces rapid and reversible inhibition [67], and extracellular Cu2+ has also been shown to inhibit ENaC through binding to multiple extracellular sites [68]. Moreover, recent reviews emphasize that copper interacts not only with ion channels themselves but also with copper-binding and copper-transporting membrane proteins, including APP, PrP, CTR1, and ATP7A/B, which participate in copper buffering, uptake, reduction, and redistribution at the cell surface [65,66].
Therefore, the effects of Cu2+ on catecholamine secretion may reflect both a disturbance of the extracellular cationic microenvironment and direct interactions with channels and membrane proteins that regulate ion fluxes and Ca2+ signaling.
In summary, acute copper exposure significantly alters cellular excitability and calcium homeostasis in chromaffin cells. Cu2+ inhibits calcium, sodium, and potassium currents involved in the initiation, propagation, and termination of action potentials, while simultaneously increasing intracellular calcium levels and enhancing neurotransmitter release. These findings suggest that copper-induced dysregulation of calcium homeostasis may play a key role in the neurotoxic effects of copper and its impact on synaptic transmission and neuronal function.
Several limitations of the present study should be acknowledged. First, the experiments were performed in primary bovine chromaffin cells, a well-established neuroendocrine model for studying cellular excitability and catecholamine secretion, but one that does not fully reproduce the complexity of synaptic transmission in intact neuronal circuits. Therefore, caution is needed when extrapolating these findings directly to central neurons or to in vivo conditions. Second, the study focused on the acute effects of Cu2+ exposure. Consequently, the results do not address the possible consequences of chronic copper accumulation, adaptive cellular responses, or long-term toxic effects, which may involve additional mechanisms such as oxidative stress, altered gene expression, mitochondrial dysfunction, or progressive impairment of membrane transport systems. Third, although our data show that Cu2+ increases basal cytosolic Ca2+ while inhibiting voltage-dependent ionic currents, the precise intracellular sources of this Ca2+ rise and the molecular targets responsible for the disruption of calcium homeostasis were not directly identified. In addition, the contribution of copper interactions with extracellular membrane surface charges, ion-channel binding sites, or copper-transporting proteins was not specifically examined in the present work.
Despite these limitations, the present findings may have several relevant applications. From a mechanistic perspective, this study provides a useful framework for understanding how acute copper exposure uncouples membrane excitability from secretory output by simultaneously inhibiting major ionic currents and increasing basal cytosolic Ca2+ levels. This may be of interest for future studies on metal-induced dysregulation of neurosecretion and on the cellular basis of copper neurotoxicity. In addition, bovine chromaffin cells may serve as an experimental platform for testing pharmacological strategies aimed at preventing copper-induced alterations in ion-channel function and calcium homeostasis. More broadly, these results may help guide future investigations into the effects of copper imbalance in excitable cells, including neuroendocrine cells and neurons, and may contribute to a better understanding of the cellular events associated with disorders of copper homeostasis.

4. Materials and Methods

4.1. Isolation and Culture of Bovine Chromaffin Cells

All procedures involving animals were conducted in accordance with the guidelines of the National Council on Animal Care and the European Communities Council Directive (86/609/EEC) and were approved by the Animal Care Committee of the Universidad Autónoma de Madrid (ES280790000092) on 18 November 2021.
Chromaffin cells, like sympathetic neurons, originate from the neural crest. Due to their neuron-like electrical excitability and their ability to synthesize, store, and release adrenaline and noradrenaline, chromaffin cells are widely used as a cellular model for studying cellular excitability and neurotransmitter release [32,33,35,36,37,38].
In accordance with bioethical animal welfare practices and European regulations (EC No. 1099/2009), Spanish legislation requires procedures that minimize animal suffering during slaughter. Adrenal glands were obtained from a local slaughterhouse under veterinary supervision. Animals were stunned using a captive bolt pistol prior to slaughter, and bleeding was initiated immediately after stunning.
Bovine chromaffin cells were isolated from the adrenal medulla by enzymatic digestion with collagenase. A total of 24 adrenal glands from 12 animals were used to obtain 12 primary cell cultures. For each primary culture, two adrenal glands were pooled before cell plating. Figure legends indicate the number of cells and the number of cultures used in each experimental group.
Cells were suspended in Dulbecco’s Modified Eagle’s Medium (DMEM, Thermo Fisher, Waltham, MA, USA) supplemented with 5% fetal bovine serum, 50 IU/mL penicillin, and 50 μg/mL streptomycin. To prevent excessive fibroblast proliferation, proliferation inhibitors were added to the culture medium (10 μM cytosine arabinoside, 10 μM fluorodeoxyuridine, and 10 μM leucine methyl ester).
For amperometric secretion experiments, cells were plated on 10 cm diameter Petri dishes at a density of 5 × 106 cells in 10 mL of DMEM. For patch-clamp experiments, cells were plated at low density on 1 cm diameter glass coverslips (5 × 104 cells per coverslip). For intracellular calcium measurements, cells were plated at a density of 2 × 105 cells per well in 96-well plates.
Cell cultures were maintained in an incubator at 37 °C in a humidified atmosphere containing 5% CO2, and cells were used between 1 and 4 days after plating.

4.2. On-Line Measurement of Neurotransmitter Release

The electrochemical method used to measure exocytosis is based on the ability of catecholamines to undergo oxidation–reduction reactions at the surface of a carbon fiber electrode [69]. Bovine chromaffin cells were carefully scraped from the bottom of Petri dishes using a rubber spatula and centrifuged at 120 g for 10 min. The resulting cell pellet was resuspended in 200 μL of Krebs–HEPES (Sigma-Aldrich/Merck KGaA, Darmstadt, Germany) solution at pH 7.4 containing (in mM): 144 NaCl, 5.9 KCl, 1.2 MgCl2, 11 glucose, 10 HEPES, and 2 CaCl2.
Cells were then placed in a microchamber (100 μL volume) and superfused at 37 °C with Krebs–HEPES solution at a flow rate of 2 mL/min. Under these conditions, the perfusion fluid leaving the microchamber reached an electrochemical detector (model CH-9100, Metrohm AG, Herisau, Switzerland) equipped with a carbon fiber microelectrode positioned at the outlet of the chamber. Catecholamines released from the cells were oxidized at a potential of 650 mV, and the resulting oxidation current was recorded at a sampling frequency of 2 Hz to monitor total catecholamine secretion.
Catecholamine release was stimulated by applying a Krebs–HEPES solution containing 35 mM KCl, with isosmotic reduction in NaCl (35K+ solution), in 5 s pulses delivered at 1 min intervals at 37 °C. After each stimulation, catecholamine release was measured in real time by amperometry [70].
The total charge (Q) released during secretion was calculated by integrating the current over time according to Faraday’s law, expressed as: Q = nNF where n is the number of electrons transferred in the redox reaction (n = 2 for catecholamines), N is the number of neurotransmitter molecules detected, and F is Faraday’s constant. Solutions were rapidly exchanged using electronically controlled valves operated by a computer.

4.3. Electrophysiological Recording and Data Analysis

Voltage-clamp recordings were performed using the whole-cell configuration of the patch-clamp technique. Patch pipettes were fabricated from thin-wall fire-polished borosilicate glass (Kimax 51, Witz Scientific, Holland, OH, USA), resulting in a final series resistance of 5–7 MΩ when filled with standard intracellular solution. Pipettes were mounted on the headstage of an EPC-9 patch-clamp amplifier and recordings were controlled using PatchMaster software version 2.92 (HEKA Electronic, Lambrecht/Pfalz, Germany). Recordings were initiated when access resistance decreased below 20 MΩ. Series resistance was compensated by 80% and continuously monitored throughout the experiments.
For recordings of Ca2+ (I_Ca), Na+ (I_Na), and K+ (I_K) currents, as well as for current-clamp experiments, data were acquired at sampling frequencies between 5 and 10 kHz and filtered at 1–2 kHz. Recording traces showing leak currents greater than 100 pA in voltage-clamp mode or series resistance greater than 20 MΩ were discarded.
During seal formation, cells were continuously perfused with Tyrode solution containing (in mM): 137 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, and 10 HEPES/NaOH (pH 7.4). After membrane rupture and establishment of the whole-cell configuration, cells were superfused with modified Tyrode solutions depending on the current being recorded. Tyrode solution containing nominally 0 mM Ca2+ was used to record INa; Tyrode solution containing 2.5 mM Ca2+ was used to record IKCa-v and IKv; and Tyrode solution containing 10 mM Ca2+ plus 1 µM tetrodotoxin (TTX) was used to record ICa in order to block sodium currents (see Section 2 for specific voltage protocols).
For INa and ICa recordings, cells were dialyzed with an intracellular solution containing (in mM): 10 NaCl, 100 CsCl, 14 EGTA, 20 TEA-Cl, 5 Mg-ATP, 0.3 Na-GTP, and 20 HEPES/CsOH (pH 7.4 adjusted with CsOH). For IK recordings and current-clamp experiments, CsCl and TEA-Cl were replaced with KCl, and pH was adjusted to 7.4 with KOH.
External solutions were exchanged using a pump-driven perfusion system at a flow rate of 2 mL/min, allowing complete solution exchange within approximately 20 s.

4.4. Monitoring of Cytosolic Calcium Levels

To monitor changes in cytosolic calcium concentration ([Ca2+]c), cells were plated at a density of 2 × 105 cells per well in black 96-well plates, and experiments were performed 48 h after plating. Cells were loaded with Krebs–HEPES solution containing (in mM): 144 NaCl, 5.9 KCl, 1.2 MgCl2, 11 glucose, 10 HEPES, and 2 CaCl2 (pH 7.4 adjusted with NaOH), supplemented with 10 µM Fluo-4 AM and 0.2% pluronic acid. Cells were incubated for 45 min at 37 °C in the dark.
After incubation, cells were washed twice with Krebs–HEPES solution at room temperature in the dark. Changes in fluorescence were measured using a fluorescence plate reader (Fluostar, BMG Labtech, Offenburg, Germany) with excitation at 485 nm and emission at 520 nm. Basal fluorescence levels were recorded before addition of the stimulation solution (35K+) using an automatic dispenser. Following stimulation, fluorescence changes were recorded for 60 s.
To normalize Fluo-4 signals, responses from each well were calibrated by measuring maximum and minimum fluorescence values. At the end of each experiment, 5% Triton X-100 was added to obtain maximal fluorescence (F_max), followed by addition of 2 mM MnCl2 to obtain minimal fluorescence (F_min). Data were expressed as a percentage of the F_max–F_min range.

4.5. Chemicals

CuCl and the salts used for preparation of saline solutions were obtained from Merck (Madrid, Spain). Collagenase type I was purchased from Roche Laboratories (Madrid, Spain). Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum (fraction V), and penicillin–streptomycin were obtained from Gibco (Madrid, Spain). Pluronic acid was purchased from Sigma-Aldrich/Merck KGaA, Germany, and Fluo-4 AM was obtained from Invitrogen (Thermo Fisher Scientific, Waltham, MA, USA). All other chemicals and reagents were purchased from Sigma-Aldrich/Merck KGaA, Germany and Panreac Chemical, Barcelona, Spain.

4.6. Statistical Analysis

Data are expressed as mean ± SEM of the number of cells studied (n), obtained from at least three independent cell cultures. Data were first evaluated for normality using the D’Agostino–Pearson omnibus normality test. Since some parameters followed a normal distribution whereas others did not, statistical comparisons were performed using the Wilcoxon matched-pairs signed-rank test in all cases. Statistical significance was established at p < 0.05. Concentration–response curves and IC50 values were obtained by fitting the data to a sigmoidal Hill equation: y = (V_max · xn)/(kn + xn). All statistical analyses and curve fittings were performed using GraphPad Prism software (version 8.01).

5. Conclusions

In the present study, we investigated the effects of acute Cu2+ exposure on ionic currents, catecholamine release, and cytosolic Ca2+ dynamics in bovine chromaffin cells. Our results show that Cu2+ exerts a dual action on these cells. On the one hand, Cu2+ increased depolarization-evoked catecholamine release and elevated basal cytosolic Ca2+ levels. On the other hand, Cu2+ inhibited voltage-dependent Ca2+, Na+, and K+ currents, as well as Ca2+/voltage-dependent K+ currents, in a concentration-dependent and partially reversible manner.
These findings demonstrate that acute Cu2+ exposure disrupts the ionic mechanisms that control cellular excitability and alters intracellular Ca2+ homeostasis in bovine chromaffin cells. The enhancement of catecholamine release despite the inhibition of inward Ca2+ current is consistent with the increase in basal cytosolic Ca2+ levels observed in the presence of Cu2+.
Overall, these findings indicate that the neurotoxic effects of Cu2+ may be associated with alterations in ionic currents that regulate cellular excitability and neurotransmitter release, as well as disruption of intracellular calcium homeostasis. These alterations may contribute to the effects of copper on neuronal function and synaptic transmission.

Author Contributions

Conceptualization, V.J.C. and J.M.H.-G.; Methodology, R.d.P. and J.M.H.-G.; Validation, V.J.C., R.d.P. and J.M.H.-G.; Formal Analysis, V.V.-T., M.R.A., V.J.C. and J.H.C.; Investigation, V.V.-T., M.R.A., M.A.T. and R.d.P.; Resources, J.M.H.-G.; Data Curation, V.V.-T., V.J.C., M.R.A., M.A.T. and R.d.P.; Writing—Original Draft Preparation, V.V.-T., V.J.C. and J.M.H.-G.; Writing—Review and Editing, V.J.C., J.H.C. and J.M.H.-G.; Visualization, V.V.-T. and V.J.C.; Supervision, R.d.P. and J.M.H.-G.; Project Administration, J.M.H.-G.; Funding Acquisition, J.M.H.-G. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by MICIU (grant number PID2021-128133NB-I00/AEI/FEDER10.13039/501100011033). Victoria Jiménez Carretero enjoys an FPI contract from the Comunidad de Madrid (PIPF-2022/SAL-GL-25948).

Institutional Review Board Statement

All procedures involving animals were conducted in accordance with the guidelines of the National Council on Animal Care and the European Communities Council Directive (86/609/EEC) and were approved by the Animal Care Committee of the Universidad Autónoma de Madrid (ES280790000092) on 18 November 2021.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Scheiber, I.; Dringen, R.; Mercer, J.F.B. Copper: Effects of Deficiency and Overload. In Interrelations Between Essential Metal Ions and Human Diseases; Metal Ions in Life Sciences; Springer: Dordrecht, The Netherlands, 2013; Volume 13, pp. 359–387. [Google Scholar] [CrossRef]
  2. Popovic, D.M.; Leontyev, I.V.; Beech, D.G.; Stuchebrukhov, A.A. Similarity of Cytochrome c Oxidases in Different Organisms. Proteins 2010, 78, 2691–2698. [Google Scholar] [CrossRef]
  3. Perry, J.J.P.; Shin, D.S.; Getzoff, E.D.; Tainer, J.A. The Structural Biochemistry of the Superoxide Dismutases. Biochim. Biophys. Acta 2010, 1804, 245–262. [Google Scholar] [CrossRef]
  4. Hellman, N.E.; Gitlin, J.D. Ceruloplasmin Metabolism and Function. Annu. Rev. Nutr. 2002, 22, 439–458. [Google Scholar] [CrossRef]
  5. Klinman, J.P. The Copper-Enzyme Family of Dopamine Beta-Monooxygenase and Peptidylglycine Alpha-Hydroxylating Monooxygenase: Resolving the Chemical Pathway for Substrate Hydroxylation. J. Biol. Chem. 2006, 281, 3013–3016. [Google Scholar] [CrossRef]
  6. Uriu-Adams, J.Y.; Scherr, R.E.; Lanoue, L.; Keen, C.L. Influence of Copper on Early Development: Prenatal and Postnatal Considerations. BioFactors 2010, 36, 136–152. [Google Scholar] [CrossRef]
  7. Rucker, R.B.; Kosonen, T.; Clegg, M.S.; Mitchell, A.E.; Rucker, B.R.; Uriu-Hare, J.Y.; Keen, C.L. Copper, Lysyl Oxidase, and Extracellular Matrix Protein Cross-Linking. Am. J. Clin. Nutr. 1998, 67, 996S–1002S. [Google Scholar] [CrossRef] [PubMed]
  8. Hung, L.W.; Villemagne, V.L.; Cheng, L.; Sherratt, N.A.; Ayton, S.; White, A.R.; Crouch, P.J.; Lim, S.; Leong, S.L.; Wilkins, S.; et al. The Hypoxia Imaging Agent CuII(Atsm) Is Neuroprotective and Improves Motor and Cognitive Functions in Multiple Animal Models of Parkinson’s Disease. J. Exp. Med. 2012, 209, 837–854. [Google Scholar] [CrossRef] [PubMed]
  9. Liu, X.; Zhang, W.; Wu, Z.; Yang, Y.; Kang, Y.J. Copper Levels Affect Targeting of Hypoxia-Inducible Factor 1α to the Promoters of Hypoxia-Regulated Genes. J. Biol. Chem. 2018, 293, 14669–14677. [Google Scholar] [CrossRef]
  10. Lutsenko, S.; Washington-Hughes, C.; Ralle, M.; Schmidt, K. Copper and the Brain Noradrenergic System. J. Biol. Inorg. Chem. JBIC Publ. Soc. Biol. Inorg. Chem. 2019, 24, 1179–1188. [Google Scholar] [CrossRef] [PubMed]
  11. Rotilio, G.; Carrì, M.T.; Rossi, L.; Ciriolo, M.R. Copper-Dependent Oxidative Stress and Neurodegeneration. IUBMB Life 2000, 50, 309–314. [Google Scholar] [CrossRef]
  12. Scheiber, I.F.; Mercer, J.F.B.; Dringen, R. Metabolism and Functions of Copper in Brain. Prog. Neurobiol. 2014, 116, 33–57. [Google Scholar] [CrossRef] [PubMed]
  13. Forte, G.; Bocca, B.; Senofonte, O.; Petrucci, F.; Brusa, L.; Stanzione, P.; Zannino, S.; Violante, N.; Alimonti, A.; Sancesario, G. Trace and Major Elements in Whole Blood, Serum, Cerebrospinal Fluid and Urine of Patients with Parkinson’s Disease. J. Neural Transm. 2004, 111, 1031–1040. [Google Scholar] [CrossRef]
  14. Nischwitz, V.; Berthele, A.; Michalke, B. Speciation Analysis of Selected Metals and Determination of Their Total Contents in Paired Serum and Cerebrospinal Fluid Samples: An Approach to Investigate the Permeability of the Human Blood-Cerebrospinal Fluid-Barrier. Anal. Chim. Acta 2008, 627, 258–269. [Google Scholar] [CrossRef]
  15. Gaier, E.D.; Eipper, B.A.; Mains, R.E. Copper Signaling in the Mammalian Nervous System: Synaptic Effects. J. Neurosci. Res. 2013, 91, 2–19. [Google Scholar] [CrossRef] [PubMed]
  16. Que, E.L.; Domaille, D.W.; Chang, C.J. Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging. Chem. Rev. 2008, 108, 1517–1549. [Google Scholar] [CrossRef] [PubMed]
  17. Davies, K.M.; Hare, D.J.; Cottam, V.; Chen, N.; Hilgers, L.; Halliday, G.; Mercer, J.F.B.; Double, K.L. Localization of Copper and Copper Transporters in the Human Brain. Met. Integr. Biometal Sci. 2013, 5, 43–51. [Google Scholar] [CrossRef]
  18. Rajan, K.S.; Colburn, R.W.; Davis, J.M. Distribution of Metal Ions in the Subcellular Fractions of Several Rat Brain Areas. Life Sci. 1976, 18, 423–431. [Google Scholar] [CrossRef]
  19. Hartter, D.E.; Barnea, A. Evidence for Release of Copper in the Brain: Depolarization-Induced Release of Newly Taken-up 67copper. Synapse 1988, 2, 412–415. [Google Scholar] [CrossRef]
  20. Hopt, A.; Korte, S.; Fink, H.; Panne, U.; Niessner, R.; Jahn, R.; Kretzschmar, H.; Herms, J. Methods for Studying Synaptosomal Copper Release. J. Neurosci. Methods 2003, 128, 159–172. [Google Scholar] [CrossRef]
  21. Lu, L.; Wang, C.; Gao, X.; Xu, P.; Wang, J.; Wang, Q.; Cheng, J.; Xiao, H. Effects of Copper on T-Type Ca2+ Channels in Mouse Spermatogenic Cells. J. Membr. Biol. 2009, 227, 87–94. [Google Scholar] [CrossRef]
  22. McGee, T.P.; Houston, C.M.; Brickley, S.G. Copper Block of Extrasynaptic GABAA Receptors in the Mature Cerebellum and Striatum. J. Neurosci. 2013, 33, 13431–13435. [Google Scholar] [CrossRef]
  23. Gasperini, L.; Meneghetti, E.; Pastore, B.; Benetti, F.; Legname, G. Prion Protein and Copper Cooperatively Protect Neurons by Modulating NMDA Receptor through S-Nitrosylation. Antioxid. Redox Signal. 2015, 22, 772–784. [Google Scholar] [CrossRef]
  24. Salazar-Weber, N.L.; Smith, J.P. Copper Inhibits NMDA Receptor-Independent LTP and Modulates the Paired-Pulse Ratio after LTP in Mouse Hippocampal Slices. Int. J. Alzheimers Dis. 2011, 2011, 864753. [Google Scholar] [CrossRef]
  25. Niu, Z.-D.; Yu, K.; Gu, Y.; Wang, M.; She, J.-Q.; Chen, W.-H.; Ruan, D.-Y. Effects of Copper on A-Type Potassium Currents in Acutely Dissociated Rat Hippocampal CA1 Neurons. NeuroReport 2005, 16, 1585–1589. [Google Scholar] [CrossRef] [PubMed]
  26. Leiva, J.; Palestini, M.; Infante, C.; Goldschmidt, A.; Motles, E. Copper Suppresses Hippocampus LTP in the Rat, but Does Not Alter Learning or Memory in the Morris Water Maze. Brain Res. 2009, 1256, 69–75. [Google Scholar] [CrossRef] [PubMed]
  27. Goldschmith, A.; Infante, C.; Leiva, J.; Motles, E.; Palestini, M. Interference of Chronically Ingested Copper in Long-Term Potentiation (LTP) of Rat Hippocampus. Brain Res. 2005, 1056, 176–182. [Google Scholar] [CrossRef] [PubMed]
  28. Kaler, S.G. ATP7A-Related Copper Transport Diseases-Emerging Concepts and Future Trends. Nat. Rev. Neurol. 2011, 7, 15–29. [Google Scholar] [CrossRef]
  29. Loudianos, G.; Gitlin, J.D. Wilson’s Disease. Semin. Liver Dis. 2000, 20, 353–364. [Google Scholar] [CrossRef]
  30. O’Brien, R.J.; Wong, P.C. Amyloid Precursor Protein Processing and Alzheimer’s Disease. Annu. Rev. Neurosci. 2011, 34, 185–204. [Google Scholar] [CrossRef]
  31. Wang, X.; Moualla, D.; Wright, J.A.; Brown, D.R. Copper Binding Regulates Intracellular Alpha-Synuclein Localisation, Aggregation and Toxicity. J. Neurochem. 2010, 113, 704–714. [Google Scholar] [CrossRef]
  32. Biales, B.; Dichter, M.; Tischler, A. Electrical Excitability of Cultured Adrenal Chromaffin Cells. J. Physiol. 1976, 262, 743–753. [Google Scholar] [CrossRef]
  33. Huber, K. The Sympathoadrenal Cell Lineage: Specification, Diversification, and New Perspectives. Dev. Biol. 2006, 298, 335–343. [Google Scholar] [CrossRef]
  34. Tischler, A.S. Chromaffin Cells as Models of Endocrine Cells and Neurons. Ann. N. Y. Acad. Sci. 2002, 971, 366–370. [Google Scholar] [CrossRef]
  35. Carbone, E.; Borges, R.; Eiden, L.E.; García, A.G.; Hernández-Cruz, A. Chromaffin Cells of the Adrenal Medulla: Physiology, Pharmacology, and Disease. Compr. Physiol. 2019, 9, 1443–1502. [Google Scholar] [CrossRef] [PubMed]
  36. Guérineau, N.C. Cholinergic and Peptidergic Neurotransmission in the Adrenal Medulla: A Dynamic Control of Stimulus-Secretion Coupling. IUBMB Life 2020, 72, 553–567. [Google Scholar] [CrossRef]
  37. García, A.G.; García-De-Diego, A.M.; Gandía, L.; Borges, R.; García-Sancho, J. Calcium Signaling and Exocytosis in Adrenal Chromaffin Cells. Physiol. Rev. 2006, 86, 1093–1131. [Google Scholar] [CrossRef]
  38. Lingle, C.J.; Martinez-Espinosa, P.L.; Guarina, L.; Carbone, E. Roles of Na+, Ca2+, and K+ Channels in the Generation of Repetitive Firing and Rhythmic Bursting in Adrenal Chromaffin Cells. Pflug. Arch. 2018, 470, 39–52. [Google Scholar] [CrossRef]
  39. Marty, A.; Neher, E. Potassium Channels in Cultured Bovine Adrenal Chromaffin Cells. J. Physiol. 1985, 367, 117–141. [Google Scholar] [CrossRef] [PubMed]
  40. Prakriya, M.; Lingle, C.J. BK Channel Activation by Brief Depolarizations Requires Ca2+ Influx through L- and Q-Type Ca2+ Channels in Rat Chromaffin Cells. J. Neurophysiol. 1999, 81, 2267–2278. [Google Scholar] [CrossRef]
  41. Prakriya, M.; Lingle, C.J. Activation of BK Channels in Rat Chromaffin Cells Requires Summation of Ca2+ Influx from Multiple Ca2+ Channels. J. Neurophysiol. 2000, 84, 1123–1135. [Google Scholar] [CrossRef] [PubMed]
  42. Pizarro, G.E.; Vargas, I.T.; Pastén, P.A.; Calle, G.R. Modeling MIC Copper Release from Drinking Water Pipes. Bioelectrochemistry 2014, 97, 23–33. [Google Scholar] [CrossRef]
  43. Alengebawy, A.; Abdelkhalek, S.T.; Qureshi, S.R.; Wang, M.-Q. Heavy Metals and Pesticides Toxicity in Agricultural Soil and Plants: Ecological Risks and Human Health Implications. Toxics 2021, 9, 42. [Google Scholar] [CrossRef]
  44. Katz, B.; Miledi, R. The Role of Calcium in Neuromuscular Facilitation. J. Physiol. 1968, 195, 481–492. [Google Scholar] [CrossRef]
  45. Takahashi, T.; Momiyama, A. Different Types of Calcium Channels Mediate Central Synaptic Transmission. Nature 1993, 366, 156–158. [Google Scholar] [CrossRef] [PubMed]
  46. Marcantoni, A.; Vandael, D.H.F.; Mahapatra, S.; Carabelli, V.; Sinnegger-Brauns, M.J.; Striessnig, J.; Carbone, E. Loss of Cav1.3 Channels Reveals the Critical Role of L-Type and BK Channel Coupling in Pacemaking Mouse Adrenal Chromaffin Cells. J. Neurosci. 2010, 30, 491–504. [Google Scholar] [CrossRef] [PubMed]
  47. Hodgkin, A.L.; Huxley, A.F. A Quantitative Description of Membrane Current and Its Application to Conduction and Excitation in Nerve. J. Physiol. 1952, 117, 500–544. [Google Scholar] [CrossRef]
  48. Sun, L.; Xiong, Y.; Zeng, X.; Wu, Y.; Pan, N.; Lingle, C.J.; Qu, A.; Ding, J. Differential Regulation of Action Potentials by Inactivating and Noninactivating BK Channels in Rat Adrenal Chromaffin Cells. Biophys. J. 2009, 97, 1832–1842, Correction in Biophys. J. 2009, 97, 2863. [Google Scholar] [CrossRef]
  49. Marrion, N.V.; Tavalin, S.J. Selective Activation of Ca2+-Activated K+ Channels by Co-Localized Ca2+ Channels in Hippocampal Neurons. Nature 1998, 395, 900–905. [Google Scholar] [CrossRef] [PubMed]
  50. Wisgirda, M.E.; Dryer, S.E. Functional Dependence of Ca2+-Activated K+ Current on L- and N-Type Ca2+ Channels: Differences between Chicken Sympathetic and Parasympathetic Neurons Suggest Different Regulatory Mechanisms. Proc. Natl. Acad. Sci. USA 1994, 91, 2858–2862. [Google Scholar] [CrossRef] [PubMed]
  51. Philipson, K.D.; Nicoll, D.A. Sodium-Calcium Exchange: A Molecular Perspective. Annu. Rev. Physiol. 2000, 62, 111–133. [Google Scholar] [CrossRef]
  52. Berrocal, M.; Mata, A.M. The Plasma Membrane Ca2+-ATPase, a Molecular Target for Tau-Induced Cytosolic Calcium Dysregulation. Neuroscience 2023, 518, 112–118. [Google Scholar] [CrossRef]
  53. Peterková, L.; Kmoníčková, E.; Ruml, T.; Rimpelová, S. Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective. J. Med. Chem. 2020, 63, 1937–1963. [Google Scholar] [CrossRef]
  54. Alevriadou, B.R.; Patel, A.; Noble, M.; Ghosh, S.; Gohil, V.M.; Stathopulos, P.B.; Madesh, M. Molecular Nature and Physiological Role of the Mitochondrial Calcium Uniporter Channel. Am. J. Physiol. Cell Physiol. 2021, 320, C465–C482. [Google Scholar] [CrossRef]
  55. Takeuchi, A.; Matsuoka, S. Physiological and Pathophysiological Roles of Mitochondrial Na+-Ca2+ Exchanger, NCLX, in Hearts. Biomolecules 2021, 11, 1876. [Google Scholar] [CrossRef]
  56. Benders, A.A.; Li, J.; Lock, R.A.; Bindels, R.J.; Bonga, S.E.; Veerkamp, J.H. Copper Toxicity in Cultured Human Skeletal Muscle Cells: The Involvement of Na+/K+-ATPase and the Na+/Ca2+-Exchanger. Pflug. Arch. 1994, 428, 461–467. [Google Scholar] [CrossRef]
  57. Viarengo, A.; Mancinelli, G.; Pertica, M.; Fabbri, R.; Orunesu, M. Effects of Heavy Metals on the Ca2+-ATPase Activity Present in Gill Cell Plasma-Membrane of Mussels (Mytilus galloprovincialis Lam.). Comp. Biochem. Physiol. C 1993, 106, 655–660. [Google Scholar] [CrossRef]
  58. Burlando, B.; Bonomo, M.; Caprì, F.; Mancinelli, G.; Pons, G.; Viarengo, A. Different Effects of Hg2+ and Cu2+ on Mussel (Mytilus galloprovincialis) Plasma Membrane Ca2+-ATPase: Hg2+ Induction of Protein Expression. Comp. Biochem. Physiol. Toxicol. Pharmacol. 2004, 139, 201–207. [Google Scholar] [CrossRef] [PubMed]
  59. Fatemi, N.; Sarkar, B. Structural and Functional Insights of Wilson Disease Copper-Transporting ATPase. J. Bioenerg. Biomembr. 2002, 34, 339–349. [Google Scholar] [CrossRef]
  60. Mandal, A.; Das, S.; Chakraborti, T.; Kar, P.; Ghosh, B.; Chakraborti, S. Solubilization, Purification and Reconstitution of Ca2+-ATPase from Bovine Pulmonary Artery Smooth Muscle Microsomes by Different Detergents: Preservation of Native Structure and Function of the Enzyme by DHPC. Biochim. Biophys. Acta 2006, 1760, 20–31. [Google Scholar] [CrossRef] [PubMed]
  61. Belyaeva, E.A.; Korotkov, S.M.; Saris, N.-E. In Vitro Modulation of Heavy Metal-Induced Rat Liver Mitochondria Dysfunction: A Comparison of Copper and Mercury with Cadmium. J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elem. 2011, 25, S63–S73. [Google Scholar] [CrossRef] [PubMed]
  62. Tuluc, P.; Carbone, E. Excitation-secretion Coupling in Chromaffin Cells of the Adrenal Gland: Where Does Calcium Come From? Pflug. Arch. 2024, 476, 3–4. [Google Scholar] [CrossRef]
  63. Jiménez-Pompa, A.; Albillos, A. Nicotinic Receptors in Human Chromaffin Cells: Characterization, Functional and Physical Interactions between Subtypes and Regulation. Int. J. Mol. Sci. 2024, 25, 2304. [Google Scholar] [CrossRef]
  64. D’Ambrosi, N.; Rossi, L. Copper at Synapse: Release, Binding and Modulation of Neurotransmission. Neurochem. Int. 2015, 90, 36–45. [Google Scholar] [CrossRef]
  65. Kardos, J.; Héja, L.; Simon, Á.; Jablonkai, I.; Kovács, R.; Jemnitz, K. Copper Signalling: Causes and Consequences. Cell Commun. Signal. 2018, 16, 71, Correction in Cell Commun. Signal. 2018, 16, 80. [Google Scholar] [CrossRef]
  66. Kawahara, M.; Tanaka, K.I.; Kato-Negishi, M. Zinc, Copper, and Calcium: A Triangle in the Synapse for the Pathogenesis of Vascular-Type Senile Dementia. Biomolecules 2024, 14, 773. [Google Scholar] [CrossRef]
  67. Ma, Z.; Wong, K.Y.; Horrigan, F.T. An Extracellular Cu2+ Binding Site in the Voltage Sensor of BK and Shaker Potassium Channels. J. Gen. Physiol. 2008, 131, 483–502. [Google Scholar] [CrossRef] [PubMed]
  68. Chen, J.; Myerburg, M.M.; Passero, C.J.; Winarski, K.L.; Sheng, S. External Cu2+ Inhibits Human Epithelial Na+ Channels by Binding at a Subunit Interface of Extracellular Domains. J. Biol. Chem. 2011, 286, 27436–27446. [Google Scholar] [CrossRef] [PubMed]
  69. Leszczyszyn, D.J.; Jankowski, J.A.; Viveros, O.H.; Diliberto, E.J.; Near, J.A.; Wightman, R.M. Nicotinic Receptor-Mediated Catecholamine Secretion from Individual Chromaffin Cells. Chemical Evidence for Exocytosis. J. Biol. Chem. 1990, 265, 14736–14737. [Google Scholar] [CrossRef] [PubMed]
  70. Green, D.J.; Perlman, R.L. On-line Measurement of Catecholamine Secretion. Anal. Biochem. 1981, 110, 270–276. [Google Scholar] [CrossRef]
Figure 1. Cu2+ potentiates the catecholamine release responses obtained in fast-superfused cells triggered by K+ stimulation. Cells were superfused with Krebs–HEPES solution containing 2 mM Ca2+ and stimulated at 1 min intervals with 10 s pulses of 35 mM K+. Cu2+ was applied during the periods indicated by the horizontal bars. (A) Averaged time course of catecholamine secretion under control conditions and during superfusion with the indicated Cu2+ concentrations (shown by the horizontal bars). Each Cu2+ concentration was tested in a separate group of cells. (B) Representative amperometric recordings obtained in control cells and during superfusion with Cu2+ (3 μM), as indicated by the horizontal bar, indicated as P1 to P22. (C) Concentration–response curve showing the effects of Cu2+ on catecholamine release. Data points represent the percentage of neurotransmitter release potentiation (ordinate axis) obtained at different Cu2+ concentrations (abscissa axis) relative to control conditions. A separate cell population was used for each concentration. The data were fitted using a nonlinear regression function (y = 674.73 − 539.55 × 0.91x) to the averaged values of catecholamine release potentiation measured at pulse P16 after Cu2+ administration.
Figure 1. Cu2+ potentiates the catecholamine release responses obtained in fast-superfused cells triggered by K+ stimulation. Cells were superfused with Krebs–HEPES solution containing 2 mM Ca2+ and stimulated at 1 min intervals with 10 s pulses of 35 mM K+. Cu2+ was applied during the periods indicated by the horizontal bars. (A) Averaged time course of catecholamine secretion under control conditions and during superfusion with the indicated Cu2+ concentrations (shown by the horizontal bars). Each Cu2+ concentration was tested in a separate group of cells. (B) Representative amperometric recordings obtained in control cells and during superfusion with Cu2+ (3 μM), as indicated by the horizontal bar, indicated as P1 to P22. (C) Concentration–response curve showing the effects of Cu2+ on catecholamine release. Data points represent the percentage of neurotransmitter release potentiation (ordinate axis) obtained at different Cu2+ concentrations (abscissa axis) relative to control conditions. A separate cell population was used for each concentration. The data were fitted using a nonlinear regression function (y = 674.73 − 539.55 × 0.91x) to the averaged values of catecholamine release potentiation measured at pulse P16 after Cu2+ administration.
Pharmaceuticals 19 00716 g001
Figure 2. Time course of the inhibition by Cu2+ of the whole-cell inward Ca2+ current. (A) Averaged time course of I_Ca under control conditions and during superfusion with different Cu2+ concentrations applied during the periods indicated by the horizontal bars. Tetrodotoxin (TTX, 1 µM) was included to prevent activation of Na+ currents. Horizontal bars indicate the superfusion periods for the Cu2+ concentrations shown on the right. A different cell was used for each Cu2+ concentration. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (30 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of ICa. Data represent the percentage of current inhibition (ordinate axis) after 2 min superfusion with each Cu2+ concentration (abscissa axis). The average data were fitted using a sigmoidal Hill equation: y = (1.10 · x0.63)/(45.710.63 + x0.63). The calculated IC50 value was 45.71 µM. Data were normalized to the mean control value and are expressed as mean ± SEM (n = 7 experiments; Wilcoxon matched-pairs signed-rank test).
Figure 2. Time course of the inhibition by Cu2+ of the whole-cell inward Ca2+ current. (A) Averaged time course of I_Ca under control conditions and during superfusion with different Cu2+ concentrations applied during the periods indicated by the horizontal bars. Tetrodotoxin (TTX, 1 µM) was included to prevent activation of Na+ currents. Horizontal bars indicate the superfusion periods for the Cu2+ concentrations shown on the right. A different cell was used for each Cu2+ concentration. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (30 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of ICa. Data represent the percentage of current inhibition (ordinate axis) after 2 min superfusion with each Cu2+ concentration (abscissa axis). The average data were fitted using a sigmoidal Hill equation: y = (1.10 · x0.63)/(45.710.63 + x0.63). The calculated IC50 value was 45.71 µM. Data were normalized to the mean control value and are expressed as mean ± SEM (n = 7 experiments; Wilcoxon matched-pairs signed-rank test).
Pharmaceuticals 19 00716 g002
Figure 3. Voltage/Ca2+-current relationship obtained before and after perfusing with Cu2+. Test depolarizing pulses were applied at the indicated voltages (abscissa axis), and the averaged current amplitude is plotted on the ordinate axis under control conditions (black trace) and after 2 min superfusion with 30 µM Cu2+ (red trace). Insets show representative current traces recorded at different test potentials under control conditions (a) and after 2 min Cu2+ superfusion (b). For each cell, data were normalized to the maximum current recorded under control conditions and are expressed as mean ± SEM (n = 5 experiments). ** p < 0.01 and *** p < 0.001 compared with control (Wilcoxon matched-pairs signed-rank test).
Figure 3. Voltage/Ca2+-current relationship obtained before and after perfusing with Cu2+. Test depolarizing pulses were applied at the indicated voltages (abscissa axis), and the averaged current amplitude is plotted on the ordinate axis under control conditions (black trace) and after 2 min superfusion with 30 µM Cu2+ (red trace). Insets show representative current traces recorded at different test potentials under control conditions (a) and after 2 min Cu2+ superfusion (b). For each cell, data were normalized to the maximum current recorded under control conditions and are expressed as mean ± SEM (n = 5 experiments). ** p < 0.01 and *** p < 0.001 compared with control (Wilcoxon matched-pairs signed-rank test).
Pharmaceuticals 19 00716 g003
Figure 4. Time course of the inhibition by Cu2+ of the whole-cell inward Na+ current. (A) Averaged time course of INa under control conditions and during superfusion with the indicated Cu2+ concentrations applied during the periods shown by the horizontal bars. Horizontal bars indicate the superfusion periods for the Cu2+ concentrations shown on the right. A different cell was used for each Cu2+ concentration. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (10 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of INa. Data represent the percentage of current inhibition (ordinate axis) measured after 2 min superfusion with each Cu2+ concentration (abscissa axis). The averaged data were fitted using a sigmoidal Hill equation: y = (0.99 · x)/(17.00 + x).
Figure 4. Time course of the inhibition by Cu2+ of the whole-cell inward Na+ current. (A) Averaged time course of INa under control conditions and during superfusion with the indicated Cu2+ concentrations applied during the periods shown by the horizontal bars. Horizontal bars indicate the superfusion periods for the Cu2+ concentrations shown on the right. A different cell was used for each Cu2+ concentration. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (10 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of INa. Data represent the percentage of current inhibition (ordinate axis) measured after 2 min superfusion with each Cu2+ concentration (abscissa axis). The averaged data were fitted using a sigmoidal Hill equation: y = (0.99 · x)/(17.00 + x).
Pharmaceuticals 19 00716 g004
Figure 5. Voltage/Na+-current relationship obtained before and after perfusing with Cu2+. Test depolarizing pulses were applied at the indicated voltages (abscissa axis), and the averaged current amplitude is plotted on the ordinate axis under control conditions (black trace) and after 2 min superfusion with 10 µM Cu2+ (red trace). Insets show representative current traces recorded at different test potentials under control conditions (a) and after 2 min Cu2+ superfusion (b). For each cell, data were normalized to the maximum current recorded under control conditions and are expressed as mean ± SEM (n = 5 cells). *** p < 0.001 compared with control (Wilcoxon matched-pairs signed-rank test).
Figure 5. Voltage/Na+-current relationship obtained before and after perfusing with Cu2+. Test depolarizing pulses were applied at the indicated voltages (abscissa axis), and the averaged current amplitude is plotted on the ordinate axis under control conditions (black trace) and after 2 min superfusion with 10 µM Cu2+ (red trace). Insets show representative current traces recorded at different test potentials under control conditions (a) and after 2 min Cu2+ superfusion (b). For each cell, data were normalized to the maximum current recorded under control conditions and are expressed as mean ± SEM (n = 5 cells). *** p < 0.001 compared with control (Wilcoxon matched-pairs signed-rank test).
Pharmaceuticals 19 00716 g005
Figure 6. Time course of the inhibition by Cu2+ of the whole-cell outward K+ current. (A) Averaged time course of I_Kv under control conditions and during superfusion with the indicated Cu2+ concentrations applied during the periods shown by the horizontal bars. Horizontal bars indicate the superfusion periods for the Cu2+ concentrations shown on the right. A different cell was used for each Cu2+ concentration. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (10 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of I_Kv. Data represent the percentage of current inhibition (ordinate axis) measured after 2 min superfusion with each Cu2+ concentration (abscissa axis). The averaged data were fitted using a sigmoidal Hill equation: y = (0.83 · x^0.52)/(11.25^0.52 + x^0.52). The calculated IC50 value was 11.25 µM. Data were normalized to the mean control value and are expressed as mean ± SEM (n = 5–7 experiments; Wilcoxon matched-pairs signed-rank test).
Figure 6. Time course of the inhibition by Cu2+ of the whole-cell outward K+ current. (A) Averaged time course of I_Kv under control conditions and during superfusion with the indicated Cu2+ concentrations applied during the periods shown by the horizontal bars. Horizontal bars indicate the superfusion periods for the Cu2+ concentrations shown on the right. A different cell was used for each Cu2+ concentration. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (10 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of I_Kv. Data represent the percentage of current inhibition (ordinate axis) measured after 2 min superfusion with each Cu2+ concentration (abscissa axis). The averaged data were fitted using a sigmoidal Hill equation: y = (0.83 · x^0.52)/(11.25^0.52 + x^0.52). The calculated IC50 value was 11.25 µM. Data were normalized to the mean control value and are expressed as mean ± SEM (n = 5–7 experiments; Wilcoxon matched-pairs signed-rank test).
Pharmaceuticals 19 00716 g006
Figure 7. Voltage/Kv-current relationship obtained before and after perfusing with Cu2+. (A) Test depolarizing pulses were applied at the indicated voltages (abscissa axis), and the averaged current amplitude is plotted on the ordinate axis under control conditions (black trace) and after 2 min superfusion with 10 µM Cu2+ (red trace). (B) Representative current traces recorded at different test potentials under control conditions (a) and after 2 min Cu2+ superfusion (b). For each cell, data were normalized to the maximum current recorded under control conditions and are expressed as mean ± SEM (n = 5 experiments). *** p < 0.001 and **** p < 0.0001 compared with control (Wilcoxon matched-pairs signed-rank test).
Figure 7. Voltage/Kv-current relationship obtained before and after perfusing with Cu2+. (A) Test depolarizing pulses were applied at the indicated voltages (abscissa axis), and the averaged current amplitude is plotted on the ordinate axis under control conditions (black trace) and after 2 min superfusion with 10 µM Cu2+ (red trace). (B) Representative current traces recorded at different test potentials under control conditions (a) and after 2 min Cu2+ superfusion (b). For each cell, data were normalized to the maximum current recorded under control conditions and are expressed as mean ± SEM (n = 5 experiments). *** p < 0.001 and **** p < 0.0001 compared with control (Wilcoxon matched-pairs signed-rank test).
Pharmaceuticals 19 00716 g007
Figure 8. Cu2+ depresses BK channel activation in a concentration dependent manner. (A) Averaged time course of I_KCa-v obtained using the protocol shown in panel B, under control conditions and during superfusion with the indicated Cu2+ concentrations applied during the periods shown by the horizontal bars. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (1 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of IKCa-v. Data represent the percentage of current inhibition (ordinate axis) measured after 2 min superfusion with each Cu2+ concentration (abscissa axis). The averaged data were fitted using a sigmoidal Hill equation: y = (0.55 · x)/(1.39 + x). The calculated IC50 value was 1.39 µM. Data were normalized to the mean control value and are expressed as mean ± SEM (n = 7 experiments; Wilcoxon matched-pairs signed-rank test).
Figure 8. Cu2+ depresses BK channel activation in a concentration dependent manner. (A) Averaged time course of I_KCa-v obtained using the protocol shown in panel B, under control conditions and during superfusion with the indicated Cu2+ concentrations applied during the periods shown by the horizontal bars. (B) Representative current traces recorded under control conditions (a) and at the end of superfusion with Cu2+ (1 µM) (b). (C) Concentration–response relationship for Cu2+-induced inhibition of IKCa-v. Data represent the percentage of current inhibition (ordinate axis) measured after 2 min superfusion with each Cu2+ concentration (abscissa axis). The averaged data were fitted using a sigmoidal Hill equation: y = (0.55 · x)/(1.39 + x). The calculated IC50 value was 1.39 µM. Data were normalized to the mean control value and are expressed as mean ± SEM (n = 7 experiments; Wilcoxon matched-pairs signed-rank test).
Pharmaceuticals 19 00716 g008
Figure 9. Voltage/K+-current curves obtained before and after perfusing with Cu2+. (A) Current–voltage (I–V) relationship of outward K+ currents recorded during test depolarizations before and after superfusion with Cu2+ (1 µM, 2 min). Note that the hump corresponding to the Ca2+/voltage-dependent K+ current is preferentially reduced after Cu2+ application. Data were normalized to the maximal control current for each cell and are expressed as mean ± SEM (n = 5 experiments). (B) Representative current traces recorded at the indicated test potentials under control conditions (a) and after superfusion with Cu2+ (1 µM, 2 min) (b). * p < 0.05, ** p < 0.01, and **** p < 0.0001 compared with control current at each potential (Wilcoxon matched-pairs signed-rank test).
Figure 9. Voltage/K+-current curves obtained before and after perfusing with Cu2+. (A) Current–voltage (I–V) relationship of outward K+ currents recorded during test depolarizations before and after superfusion with Cu2+ (1 µM, 2 min). Note that the hump corresponding to the Ca2+/voltage-dependent K+ current is preferentially reduced after Cu2+ application. Data were normalized to the maximal control current for each cell and are expressed as mean ± SEM (n = 5 experiments). (B) Representative current traces recorded at the indicated test potentials under control conditions (a) and after superfusion with Cu2+ (1 µM, 2 min) (b). * p < 0.05, ** p < 0.01, and **** p < 0.0001 compared with control current at each potential (Wilcoxon matched-pairs signed-rank test).
Pharmaceuticals 19 00716 g009
Figure 10. Effects of Cu2+ on basal and K+-evoked cytosolic Ca2+ signals in fluo-4-loaded BCCs. Cells seeded in black 96-well plates were exposed to increasing concentrations of Cu2+ 10 s before stimulation with a depolarizing pulse of 35 mM K+. (A) Family of cytosolic calcium concentration ([Ca2+]c) traces normalized to the initial baseline obtained under control conditions and in the presence of the indicated Cu2+ concentrations. Calibration bars indicate changes in arbitrary fluorescence units (AFU) versus time (s). (B) Representative [Ca2+]c signals elicited by 35 mM K+ expressed in absolute AFU (ordinate axis) versus time (abscissa axis), recorded under control conditions and after exposure of the cells to increasing Cu2+ concentrations. Note the increase in basal [Ca2+]c levels in the presence of Cu2+. Curves represent averages from 9 experiments performed in two different cell cultures. (C) Quantitative averaged data showing the net increase in [Ca2+]c elicited by 35 mM K+ in the absence (control) and presence of Cu2+ (indicated on the bottom horizontal line). Data were normalized to the peak control response and are expressed as mean ± SEM. (D) Net increases in basal fluorescence (Δ basal − basal control, AFU) induced by increasing Cu2+ concentrations prior to stimulation with 35 mM K+. Data in (C,D) are expressed as mean ± SEM of 6 experiments from two different cell cultures. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with control.
Figure 10. Effects of Cu2+ on basal and K+-evoked cytosolic Ca2+ signals in fluo-4-loaded BCCs. Cells seeded in black 96-well plates were exposed to increasing concentrations of Cu2+ 10 s before stimulation with a depolarizing pulse of 35 mM K+. (A) Family of cytosolic calcium concentration ([Ca2+]c) traces normalized to the initial baseline obtained under control conditions and in the presence of the indicated Cu2+ concentrations. Calibration bars indicate changes in arbitrary fluorescence units (AFU) versus time (s). (B) Representative [Ca2+]c signals elicited by 35 mM K+ expressed in absolute AFU (ordinate axis) versus time (abscissa axis), recorded under control conditions and after exposure of the cells to increasing Cu2+ concentrations. Note the increase in basal [Ca2+]c levels in the presence of Cu2+. Curves represent averages from 9 experiments performed in two different cell cultures. (C) Quantitative averaged data showing the net increase in [Ca2+]c elicited by 35 mM K+ in the absence (control) and presence of Cu2+ (indicated on the bottom horizontal line). Data were normalized to the peak control response and are expressed as mean ± SEM. (D) Net increases in basal fluorescence (Δ basal − basal control, AFU) induced by increasing Cu2+ concentrations prior to stimulation with 35 mM K+. Data in (C,D) are expressed as mean ± SEM of 6 experiments from two different cell cultures. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with control.
Pharmaceuticals 19 00716 g010
Figure 11. Proposed mechanism underlying the effects of Cu2+ on ionic currents, cytosolic Ca2+, and catecholamine release in bovine chromaffin cells. Acute Cu2+ exposure inhibits major voltage-dependent ionic currents, including Ca2+ currents (ICa), Na+ currents (INa), voltage-dependent K+ currents (IKv), and Ca2+/voltage-dependent K+ currents (IKCa-v, BK). As a consequence, Cu2+ reduces Ca2+ influx and decreases the amplitude of K+-evoked cytosolic Ca2+ transients. At the same time, Cu2+ increases basal cytosolic Ca2+ levels. The combined effect of these actions may explain the paradoxical potentiation of catecholamine release observed in the presence of Cu2+, suggesting that disruption of intracellular Ca2+ homeostasis facilitates exocytosis despite the inhibition of ionic currents involved in cellular excitability.
Figure 11. Proposed mechanism underlying the effects of Cu2+ on ionic currents, cytosolic Ca2+, and catecholamine release in bovine chromaffin cells. Acute Cu2+ exposure inhibits major voltage-dependent ionic currents, including Ca2+ currents (ICa), Na+ currents (INa), voltage-dependent K+ currents (IKv), and Ca2+/voltage-dependent K+ currents (IKCa-v, BK). As a consequence, Cu2+ reduces Ca2+ influx and decreases the amplitude of K+-evoked cytosolic Ca2+ transients. At the same time, Cu2+ increases basal cytosolic Ca2+ levels. The combined effect of these actions may explain the paradoxical potentiation of catecholamine release observed in the presence of Cu2+, suggesting that disruption of intracellular Ca2+ homeostasis facilitates exocytosis despite the inhibition of ionic currents involved in cellular excitability.
Pharmaceuticals 19 00716 g011
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Varea-Tierno, V.; Carretero, V.J.; Almodóvar, M.R.; Hernández Campano, J.; Tejedor, M.A.; de Pascual, R.; Hernández-Guijo, J.M. Copper (Cu2+) Inhibits Voltage-Dependent Ionic Currents While Enhancing Neurotransmitter Release in Bovine Chromaffin Cells. Pharmaceuticals 2026, 19, 716. https://doi.org/10.3390/ph19050716

AMA Style

Varea-Tierno V, Carretero VJ, Almodóvar MR, Hernández Campano J, Tejedor MA, de Pascual R, Hernández-Guijo JM. Copper (Cu2+) Inhibits Voltage-Dependent Ionic Currents While Enhancing Neurotransmitter Release in Bovine Chromaffin Cells. Pharmaceuticals. 2026; 19(5):716. https://doi.org/10.3390/ph19050716

Chicago/Turabian Style

Varea-Tierno, Víctor, Victoria Jiménez Carretero, Minerva Reyes Almodóvar, Javier Hernández Campano, María Arribas Tejedor, Ricardo de Pascual, and Jesús M. Hernández-Guijo. 2026. "Copper (Cu2+) Inhibits Voltage-Dependent Ionic Currents While Enhancing Neurotransmitter Release in Bovine Chromaffin Cells" Pharmaceuticals 19, no. 5: 716. https://doi.org/10.3390/ph19050716

APA Style

Varea-Tierno, V., Carretero, V. J., Almodóvar, M. R., Hernández Campano, J., Tejedor, M. A., de Pascual, R., & Hernández-Guijo, J. M. (2026). Copper (Cu2+) Inhibits Voltage-Dependent Ionic Currents While Enhancing Neurotransmitter Release in Bovine Chromaffin Cells. Pharmaceuticals, 19(5), 716. https://doi.org/10.3390/ph19050716

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop